Literature DB >> 10219786

Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment.

G J Biessels1, N A Cristino, G J Rutten, F P Hamers, D W Erkelens, W H Gispen.   

Abstract

Diabetes mellitus can affect both the peripheral and the central nervous system. However, central deficits are documented less well than peripheral deficits. We therefore compared the course of development of neurophysiological changes in the central and peripheral nervous systems in streptozotocin-diabetic rats. Sciatic nerve conduction velocities and auditory and visual evoked potentials were measured prior to diabetes induction, and then monthly after diabetes induction for 6 months. In addition, the effect of insulin treatment was examined. Treatment was initiated after a diabetes duration of 6 months and was continued for 3 months. During treatment, evoked potentials and nerve conduction were measured monthly. In a third experiment, conduction velocities in ascending and descending pathways of the spinal cord were examined after 3 and 6 months of diabetes. Impairments of sciatic nerve conduction velocities developed fully during the first 2-3 months of diabetes. In contrast, increased latencies of auditory and visual evoked potentials developed only after 3-4 months of diabetes, and progressed gradually thereafter. Insulin treatment, initiated 6 months after induction of diabetes, improved both nerve conduction velocities and evoked potential latencies. Conduction velocities in the spinal cord tended to be reduced after 3 months of diabetes and were significantly reduced after 6 months of diabetes. The present study demonstrates that in streptozotocin-diabetic rats the course of development of peripheral and central neurophysiological changes differs. Peripheral impairments develop within weeks after diabetes induction, whereas central impairments take months to develop. Insulin can reverse both peripheral and central neurophysiological alterations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219786     DOI: 10.1093/brain/122.4.757

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  28 in total

1.  The chronological characteristics of SOD1 activity and inflammatory response in the hippocampi of STZ-induced type 1 diabetic rats.

Authors:  Sun Shin Yi; In Koo Hwang; Dae Won Kim; Jae Hoon Shin; Sung Min Nam; Jung Hoon Choi; Choong Hyun Lee; Moo-Ho Won; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2010-10-06       Impact factor: 3.996

Review 2.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

3.  Molecular mimicry: sensitization of Lewis rats with Campylobacter jejuni lipopolysaccharides induces formation of antibody toward GD3 ganglioside.

Authors:  Seigo Usuki; Stuart A Thompson; Michael H Rivner; Kyoji Taguchi; Keiko Shibata; Toshio Ariga; Robert K Yu
Journal:  J Neurosci Res       Date:  2006-02-01       Impact factor: 4.164

4.  Reduced gap junctional communication among astrocytes in experimental diabetes: contributions of altered connexin protein levels and oxidative-nitrosative modifications.

Authors:  Kelly K Ball; Lamia Harik; Gautam K Gandhi; Nancy F Cruz; Gerald A Dienel
Journal:  J Neurosci Res       Date:  2011-05-02       Impact factor: 4.164

5.  Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy.

Authors:  L K Bhatt; Addepalli Veeranjaneyulu
Journal:  Neurol Sci       Date:  2010-03-06       Impact factor: 3.307

6.  Identification of differentially expressed genes in dorsal root ganglion in early diabetic rats.

Authors:  Qing Zhu; Jin-Hua Gu; Hong-Yan Zhu; Ji-Liang Xu
Journal:  Neurosci Bull       Date:  2008-08       Impact factor: 5.203

7.  Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation.

Authors:  Li-ping Liu; Tian-hua Yan; Li-ying Jiang; Wei Hu; Meng Hu; Chao Wang; Qian Zhang; Yan Long; Jiang-qing Wang; Yong-qi Li; Mei Hu; Hao Hong
Journal:  Acta Pharmacol Sin       Date:  2013-03-25       Impact factor: 6.150

8.  Global transcriptional programs in peripheral nerve endoneurium and DRG are resistant to the onset of type 1 diabetic neuropathy in Ins2 mice.

Authors:  Anne-Sophie de Preux Charles; Valérie Verdier; Jennifer Zenker; Bastian Peter; Jean-Jacques Médard; Thierry Kuntzer; Jacques S Beckmann; Sven Bergmann; Roman Chrast
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

9.  Hyperglycaemia and diabetes impair gap junctional communication among astrocytes.

Authors:  Gautam K Gandhi; Kelly K Ball; Nancy F Cruz; Gerald A Dienel
Journal:  ASN Neuro       Date:  2010-03-15       Impact factor: 4.146

10.  Interactions of hearing loss and diabetes mellitus in the middle age CBA/CaJ mouse model of presbycusis.

Authors:  Olga N Vasilyeva; Susan T Frisina; Xiaoxia Zhu; Joseph P Walton; Robert D Frisina
Journal:  Hear Res       Date:  2009-03       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.